Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lactobreath: A Pilot Study to Diagnose Lactose Intolerance Based on the Exhaled Breath Metabolome

NCT06177938 is registered in ClinicalTrials.gov with ETH Zurich as lead sponsor.

NCT NCT06177938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06177938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lactobreath: A Pilot Study to Diagnose Lactose Intolerance Based on the Exhaled Breath Metabolome
Lead sponsor
ETH Zurich
Phase
Not applicable
Overall status
Completed
Start date
June 24, 2024
Completion date
April 1, 2026
Enrollment
112 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lactose intolerance